InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Mor George Adi. Director active across 1 company, notably Chemomab Therapeutics Ltd.. Cumulatively, 6 disclosures have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €707k. History available since 16 November 2022. The latest transaction was filed on 29 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Mor George Adi is a declarant linked to Chemomab Therapeutics Ltd. (XNAS), where the listed role is Chief Executive Officer. Across 6 filings in total, the 6 sampled filings run from 2022-11-17 to 2026-06-01, with buy volume of EUR 17432 and sell volume of EUR 689947 in that recent sample.